Semax in women’s basketball: conflicting tables and prose
E. A. Orlova, Ya. S. Rybalkina, A. V. Dorontsev, O. V. Morozova · 2025 · Original journal text, methods and Table 1
Indexed 2026-11-09.
Related evidence maps: Sports performance ↗
Reported findings and study design
The narrative reports nonsignificant shooting changes. The table labels and direction conflict with the prose, preventing confident assignment of a benefit.
Competition and practice metrics, with five-minute 100–200 W cycle ergometry and early/late recovery measurements.
Dose, route and schedule
Intranasal Semax, identified as 0.5% in results; methods give 200–2,000 µg per administration and 500–5,000 µg per day for seven precompetition and seven competition days. Individual delivered doses are unclear.
Protocol source ↗ · Original journal text, methods and Table 1
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Reported free-throw change | 17.3±2.6%; p=0.37 | Narrative comparison. No significant result. |
| Reported three-point change | 9.5±1.7%; p=0.44 | Narrative comparison. No significant result. |
| Sample-size conflict | 28 in methods versus 40 in the table | Several larger changes appear in the column labelled comparison. Allocation cannot be reconstructed. |
The inconsistent sample and table headings prevent a reliable treatment estimate.
Source for the extracted data ↗ · Checked 2026-11-09
Molekul summary of the linked publication. Educational information, not medical advice. Seek qualified healthcare help for medical conditions.
Methods, limitations & source review
Study limitations
- The inconsistent sample and table headings prevent a reliable treatment estimate.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Document format: Original journal text, methods and Table 1
Review depth: Reported methods, results and evidence limitations
Source access and review scope
Original journal text, methods and Table 1
Recorded source-check date: 2026-11-09. This date does not imply a completed systematic review.
Source type: Original journal text, methods and Table 1
Citation and original source
Original source: E. A. Orlova, Ya. S. Rybalkina, A. V. Dorontsev, O. V. Morozova. Semax in women’s basketball: conflicting tables and prose Original journal text, methods and Table 1 2025.
Molekul research summary: https://molekul.io/research/orlov-basketball-semax-2025. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry